# Evaluation of the Effect of Roflumilast in Hyperinflated COPD Patients Using Functional Respiratory Imaging

> **NCT02451540** · PHASE2 · TERMINATED · sponsor: **FLUIDDA nv** · enrollment: 13 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **RADIATION:** HRCT scan
- **DRUG:** Placebo of Roflumilast
- **DRUG:** Roflumilast

## Key facts

- **NCT ID:** NCT02451540
- **Lead sponsor:** FLUIDDA nv
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09
- **Primary completion:** 2017-08-31
- **Final completion:** 2017-08-31
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** No new investigational product can be delivered to the site.
- **Last updated:** 2018-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02451540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02451540, "Evaluation of the Effect of Roflumilast in Hyperinflated COPD Patients Using Functional Respiratory Imaging". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02451540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*